[Usefulness of bevacizumab combination chemotherapy for advanced breast cancer].

Aomatsu, Naoki; Kashiwagi, Shinichiro; Morisaki, Tamami; Ishihara, Sae; Asano, Yuka; Watanabe, Mao; Noda, Satoru; Kawajiri, Hidemi; Takashima, Tsutomu; Onoda, Naoyoshi; Ishikawa, Tetsuro; Hirakawa, Kosei

Aomatsu, Naoki; Kashiwagi, Shinichiro; Morisaki, Tamami; Ishihara, Sae; Asano, Yuka; Watanabe, Mao; Noda, Satoru; Kawajiri, Hidemi; Takashima, Tsutomu; Onoda, Naoyoshi; Ishikawa, Tetsuro; Hirakawa, Kosei.

Affiliation

Aomatsu N; Dept. of Surgical Oncology, Osaka City University Graduate School of Medicine.

Gan To Kagaku Ryoho ; 40(12): 2393-5, 2013 Nov.

Article in Ja | MEDLINE | ID: mdl-24394123

Subject(s)

Antibodies, Monoclonal, Humanized/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Adult; Aged; Antibodies, Monoclonal, Humanized/adverse effects; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Bevacizumab; Breast Neoplasms/pathology; Female; Humans; Middle Aged; Neoplasm Metastasis; Paclitaxel/administration & dosage; Paclitaxel/adverse effects

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antibodies, Monoclonal, Humanized Limits: Adult / Aged / Female / Humans / Middle aged Language: Ja Year: 2013 Type: Article

Search on Google

XML

PubMed Links